287 related articles for article (PubMed ID: 1899494)
1. Physiologic basis of endocrine therapy for prostatic cancer.
McConnell JD
Urol Clin North Am; 1991 Feb; 18(1):1-13. PubMed ID: 1899494
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced prostatic cancer.
Sogani PC; Fair WR
Urol Clin North Am; 1987 May; 14(2):353-71. PubMed ID: 2953100
[TBL] [Abstract][Full Text] [Related]
3. Complete androgen blockade for the treatment of prostate cancer.
Labrie F; Dupont A; Belanger A
Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
[No Abstract] [Full Text] [Related]
4. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
5. Newer methods of hormonal therapy for prostate cancer.
Soloway MS
Urology; 1984 Nov; 24(5 Suppl):30-8. PubMed ID: 6437034
[TBL] [Abstract][Full Text] [Related]
6. Advanced prostate cancer. Hormonal treatment.
de la Haba-Rodríguez J
Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
[No Abstract] [Full Text] [Related]
7. Maximal androgen ablation: a review.
Miles BJ; Babiarz J
Henry Ford Hosp Med J; 1992; 40(1-2):114-7. PubMed ID: 1428961
[TBL] [Abstract][Full Text] [Related]
8. Endocrine therapy for prostate cancer.
Labrie F
Endocrinol Metab Clin North Am; 1991 Dec; 20(4):845-72. PubMed ID: 1778180
[TBL] [Abstract][Full Text] [Related]
9. Treating prostate cancer. Part V: androgen deprivation and chemotherapy.
Harv Mens Health Watch; 1999 Dec; 4(5):5-8. PubMed ID: 10564905
[No Abstract] [Full Text] [Related]
10. Androgen deprivation therapy for prostate cancer: current status and future prospects.
Miyamoto H; Messing EM; Chang C
Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811
[TBL] [Abstract][Full Text] [Related]
11. [Hormonal therapy (medical orchiectomy) in prostatic carcinoma].
Studer UE; Münch D
Schweiz Med Wochenschr; 1990 Jun; 120(24):881-7. PubMed ID: 2193381
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
13. Endocrine therapy for prostate cancer.
Sagalowsky AI
Spec Top Endocrinol Metab; 1985; 7():101-29. PubMed ID: 3914094
[TBL] [Abstract][Full Text] [Related]
14. [The potential hormonal therapy of prostatic carcinoma].
Studer UE; Altwein J; Bartsch G
Urologe A; 1991 Sep; 30(5):310-6. PubMed ID: 1949440
[TBL] [Abstract][Full Text] [Related]
15. Hormonal ablation therapy for metastatic prostatic carcinoma: a review.
Leewansangtong S; Soontrapa S
J Med Assoc Thai; 1999 Feb; 82(2):192-205. PubMed ID: 10087729
[TBL] [Abstract][Full Text] [Related]
16. Principles of endocrine manipulation in the treatment of prostatic cancer.
Neumann F
Prog Clin Biol Res; 1985; 185A():73-98. PubMed ID: 3898136
[No Abstract] [Full Text] [Related]
17. Endocrine therapy for prostate cancer.
Damber JE
Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
[TBL] [Abstract][Full Text] [Related]
18. [New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Dubost JJ; Sauvezie B; Ristori JM; Thevenet JP; Rampon S
Rev Rhum Mal Osteoartic; 1985 Oct; 52(10):577-85. PubMed ID: 3909364
[No Abstract] [Full Text] [Related]
19. Maximal androgen blockade versus total androgen suppression.
Dumez H; Van Poppel H; Baert L; Paridaens R
Acta Urol Belg; 1997 Mar; 65(1):49-54. PubMed ID: 9175283
[TBL] [Abstract][Full Text] [Related]
20. Combined androgen blockade: the gold standard for metastatic prostate cancer.
McLeod DG; Crawford ED; DeAntoni EP
Eur Urol; 1997; 32 Suppl 3():70-7. PubMed ID: 9267789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
